Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-631
Closed -$6K 1206
2020
Q3
$6K Sell
631
-81
-11% -$918 ﹤0.01% 2024
2020
Q2
$7K Buy
712
+243
+52% +$2.51K ﹤0.01% 1975
2020
Q1
$4K Hold
469
﹤0.01% 2701
2019
Q4
$4K Sell
469
-114
-20% -$1.09K ﹤0.01% 2701
2019
Q3
$6 Buy
583
+220
+61% +$2.61K ﹤0.01% 2553
2019
Q2
$5 Hold
363
﹤0.01% 2613
2019
Q1
$4 Hold
363
﹤0.01% 2653
2018
Q4
$3 Buy
+363
New +$4.95K ﹤0.01% 2650
2018
Q2
Sell
-554
Closed -$10K 1925
2018
Q1
$10K Hold
554
﹤0.01% 2170
2017
Q4
$10K Buy
554
+379
+217% +$8.41K ﹤0.01% 2170
2017
Q3
$4K Hold
175
﹤0.01% 2385
2017
Q2
$3K Hold
175
﹤0.01% 2383
2017
Q1
$3K Buy
+175
New +$3.8K ﹤0.01% 2383
2016
Q4
Sell
-69
Closed -$1K 2461
2016
Q3
$1K Hold
69
﹤0.01% 2447
2016
Q2
$1K Sell
69
-155
-69% -$2.95K ﹤0.01% 2451
2016
Q1
$4K Buy
224
+69
+45% +$1.28K ﹤0.01% 2257
2015
Q4
$1K Hold
155
﹤0.01% 2535
2015
Q3
$1K Hold
155
﹤0.01% 2581
2015
Q2
$1K Buy
+155
New +$2.66K ﹤0.01% 2520
2014
Q4
Sell
-8,243
Closed -$169K 2518
2014
Q3
$169K Sell
8,243
-6,894
-46% -$154K ﹤0.01% 1234
2014
Q2
$341K Hold
15,137
﹤0.01% 1007
2014
Q1
$369K Buy
+15,137
New +$390K ﹤0.01% 966

Other funds holding ADTN

Glenmede Trust's ADTN Position: Q4 2020 in Review

Glenmede Trust sold out of Adtran (ADTN) in Q4 2020, closing a stake of 631 shares — an estimated $6K sold.

Glenmede Trust first reported a position in ADTN in Q1 2014 and held it in 22 quarters. The position peaked at $369K in Q1 2014. 141 funds tracked by Wall St. Rank hold ADTN as of Q4 2020.

  • Glenmede Trust reported no remaining Adtran position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 631 Adtran shares in Q4 2020, an estimated $6K.
  • Glenmede Trust first reported a position in Adtran in Q1 2014 and held it in 22 quarters.
  • Glenmede Trust's Adtran position peaked at $369K in Q1 2014.
  • 141 funds tracked by Wall St. Rank held Adtran as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.